Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding Compositions - EP4084799

The patent EP4084799 was granted to Nuvamid on Apr 17, 2024. The application was originally filed on Jan 12, 2021 under application number EP21701672A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4084799

NUVAMID
Application Number
EP21701672A
Filing Date
Jan 12, 2021
Status
Granted And Under Opposition
Mar 15, 2024
Grant Date
Apr 17, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SCHLICHMay 30, 2024SCHLICHADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2017024255
EXAMINATIONWO2017024255
EXAMINATIONWO2020131578
INTERNATIONAL-SEARCH-REPORTUS2017080011
INTERNATIONAL-SEARCH-REPORTUS2017266213
INTERNATIONAL-SEARCH-REPORTWO2019222360
INTERNATIONAL-SEARCH-REPORTWO2019222368

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents